Abstract:Abstract The injury of glomerular visceral epithelial cells (podocytes) is the initial target in FSGS. However, podocytes are terminally differentiated cells in the glomerular and can hardly regenerate. Recent studies have shown that parietal epithelial cells (PECs) are potential stem cells in the glomerulus, which are able to differentiate into podocytes and participate in the regeneration and repair of podocytes after injury. Whereas the specific mechanism of regulation of PECs differentiating to podocytes remains unclear. Here, we found several podocytes also expressed PECs marker claudin-1 in ADR nephropathy mice. Podocyte markers WT-1, FOXC1, synaptopodin and podocin were upregulated after PECs differentiating into podocytes in vitro. After inhibition of total and mitochondrial ROS, PECs differentiation into podocytes decreased. Further studies showed that the expression of ROS related molecule Nrf2 and its target protein Brg1 increased after PECs were induced, while inhibition of Nrf2 or Brg1 reduced PECs transdifferentiation, and the overexpression of Nrf2 or Brg1 showed the opposite result. Brg1 directly regulates WT-1 transcription in PECs. We also observed an increase in WT1 positive cells at ADR damage in mice with PAX8 conditional overexpression of NRF2. We conclude when PECs are stimulated by extracellular signals, the high expression of WT-1 transcription factor in podocytes can be regulated by ROS-Nrf2-Brg1 signal, thus differentiating into podocytes.

Parietal epithelial cells differentiate into podocytes dependent on ROS-Nrf2-Brg1 signaling